The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Join ShareProphets at less than 2p per article

> All the big AIM fraud exposés

> 300 articles and podcasts a month

> Hot share tips

> Original investigations by our experienced team

> No ads, no click-bait, no auto-play videos

Find out more

Advanced Oncotherapy - now about Tim Lebus

By Tom Winnifrith | Friday 2 December 2016

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Tim Lebus is a non executive director at Advanced Oncotherapy (AVO). Well sort of.

It seems that Advanced is having problems hanging onto board members. On 10th October Mr Kanoria stepped down from the board in a planned departure. A month later it was Tony Blair crony Lord Evans who "was resigned" after we pointed out that he had dumped all his shares in a closed period and just before a major placing.

Now there is Tim Lebus. Perhaps Advanced would care to comment on speculation that he handed in his notice as a NED in October. If so when exactly was Advanced thinking of letting us know that someone else was leaving its sinking ship? 

To lose two directors is understandable but to lose three would start to look like carelessness. Or as if something was badly wrong. Which, of course, it is. 

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on AVO


Comments are turned off for this article.

Site by Everywhen